Leerink Partners Reiterates Outperform Rating on Biohaven Pharma (BHVN), lowers EPS estimates

Go back to Leerink Partners Reiterates Outperform Rating on Biohaven Pharma (BHVN), lowers EPS estimates
(NYSE: BHVN) Delayed: 14.85 --0 (-0%)
Previous Close $14.85    52 Week High
Open $14.85    52 Week Low
Day High $14.85    P/E N/A 
Day Low $14.85    EPS
Volume 14,790